Guozhong Z. Jiang

No. 1 Jianshe East Road
Zhengzhou, 450000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Multiple recurrences with orbital invasion arising from primary sinonasal solitary fibrous tumor: report of a case

Multiple recurrences with orbital invasion arising from primary sinonasal solitary fibrous tumor: report of a case

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: June 30, 2026

AI-guided discovery of the IRF4-PAICS-LDHA axis as a multitarget hub linking tumor metabolism to CD8+ T cell exhaustion in DLBCL.

AI-guided discovery of the IRF4-PAICS-LDHA axis as a multitarget hub linking tumor metabolism to CD8+ T cell exhaustion in DLBCL.

Journal: NPJ precision oncology

Published: December 26, 2025

Research progress of MicroRNA in lung cancer.

Research progress of MicroRNA in lung cancer.

Journal: Discover oncology

Published: September 03, 2025

CD27 expression is a clinically accessible biomarker for predicting immunotherapy response in melanoma.

CD27 expression is a clinically accessible biomarker for predicting immunotherapy response in melanoma.

Journal: NPJ precision oncology

Published: June 09, 2025

Molecular classification and fertility-sparing outcomes in endometrial cancer and atypical endometrial hyperplasia.

Molecular classification and fertility-sparing outcomes in endometrial cancer and atypical endometrial hyperplasia.

Journal: Biomolecules & biomedicine

Published: March 23, 2025

BTLA promoter hypomethylation correlates with enhanced immune cell infiltration, favorable prognosis, and immunotherapy response in melanoma.

BTLA promoter hypomethylation correlates with enhanced immune cell infiltration, favorable prognosis, and immunotherapy response in melanoma.

Journal: Journal for immunotherapy of cancer

Published: February 17, 2025

Anlotinib combined with benmelstobart as a chemo-free first-line treatment in advanced esophageal squamous cell carcinoma: an exploratory multicenter, single-arm phase II clinical trial.

Anlotinib combined with benmelstobart as a chemo-free first-line treatment in advanced esophageal squamous cell carcinoma: an exploratory multicenter, single-arm phase II clinical trial.

Journal: Molecular cancer

Published: January 25, 2025

Construction of a novel cuproptosis-related gene signature and integrative analyses in cholangiocarcinoma.

Construction of a novel cuproptosis-related gene signature and integrative analyses in cholangiocarcinoma.

Journal: Heliyon

Published: August 04, 2024

Efficacy and safety of camrelizumab plus apatinib in patients with advanced esophageal squamous cell carcinoma previously treated with immune checkpoint inhibitors (CAP 02 Re-challenge): A single-arm, phase II study.

Efficacy and safety of camrelizumab plus apatinib in patients with advanced esophageal squamous cell carcinoma previously treated with immune checkpoint inhibitors (CAP 02 Re-challenge): A single-arm, phase II study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 02, 2024

Analytical and clinical validation of a NGS panel in detecting targetable variants from ctDNA of metastatic NSCLC patients.

Analytical and clinical validation of a NGS panel in detecting targetable variants from ctDNA of metastatic NSCLC patients.

Journal: Cancer medicine

Published: April 29, 2024

Nuclear autoantigenic sperm protein facilitates glioblastoma progression and radioresistance by regulating the ANXA2/STAT3 axis.

Nuclear autoantigenic sperm protein facilitates glioblastoma progression and radioresistance by regulating the ANXA2/STAT3 axis.

Journal: CNS neuroscience & therapeutics

Published: December 12, 2023

Molecular landscape and clinical significance of exon 11 mutations in KIT gene among patients with gastrointestinal stromal tumor: a retrospective exploratory study.

Molecular landscape and clinical significance of exon 11 mutations in KIT gene among patients with gastrointestinal stromal tumor: a retrospective exploratory study.

Journal: Frontiers in oncology

Published: August 03, 2023

Showing 1-12 of 57

Last Updated: 09/26/2026